Adial Pharmaceuticals Stock Analysis

Adial Stock Analysis Notes

The book value of the company was presently reported as 0.32. The company recorded a loss per share of 0.87. Adial Pharmaceuticals had not issued any dividends in recent years. The entity had 1:25 split on the 7th of August 2023. Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia. Adial Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people. For more info on Adial Pharmaceuticals please contact Cary MBA at (804) 487-8196 or go to https://www.adial.com.

Adial Pharmaceuticals Investment Alerts

Adial Pharmaceuticals Upcoming and Recent Events

Adial Largest EPS Surprises

View All Earnings Estimates

Adial Stock Institutional Investors

Note, although Adial Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Adial Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.12 M.

Adial Profitablity

Management Efficiency

Adial Pharmaceuticals has return on total asset (ROA) of (1.0738) % which means that it has lost $1.0738 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.1701) %, meaning that it created substantial loss on money invested by shareholders. Adial Pharmaceuticals' management efficiency ratios could be used to measure how well Adial Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -2.75. The value of Return On Capital Employed is expected to slide to -2.14. At this time, Adial Pharmaceuticals' Non Currrent Assets Other are quite stable compared to the past year. Other Assets is expected to rise to about 422.6 K this year, although the value of Net Tangible Assets will most likely fall to about 2.7 M.

Technical Drivers

As of the 20th of July, Adial Pharmaceuticals shows the Downside Deviation of 12.12, risk adjusted performance of 0.0147, and Mean Deviation of 6.75. Adial Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Adial Pharmaceuticals variance, as well as the relationship between the maximum drawdown and semi variance to decide if Adial Pharmaceuticals is priced correctly, providing market reflects its regular price of 0.45 per share. As Adial Pharmaceuticals is a penny stock we also strongly suggest to validate its total risk alpha numbers.

Adial Pharmaceuticals Price Movement Analysis

Adial Pharmaceuticals Insider Trading Activities

Adial Pharmaceuticals Outstanding Bonds

Adial Pharmaceuticals Predictive Daily Indicators

Adial Pharmaceuticals Forecast Models

Adial Pharmaceuticals' time-series forecasting models are one of many Adial Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Adial Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Adial Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Adial shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Adial Pharmaceuticals. By using and applying Adial Stock analysis, traders can create a robust methodology for identifying Adial entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Adial analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Adial analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Adial Pharmaceuticals stock analysis indicators help investors evaluate how Adial Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Adial Pharmaceuticals shares will generate the highest return on investment. By understating and applying Adial Pharmaceuticals stock analysis, traders can identify Adial Pharmaceuticals position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adial Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Adial Stock please use our How to buy in Adial Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adial Pharmaceuticals. If investors know Adial will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adial Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Adial Pharmaceuticals is measured differently than its book value, which is the value of Adial that is recorded on the company's balance sheet. Investors also form their own opinion of Adial Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Adial Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adial Pharmaceuticals' market value can be influenced by many factors that don't directly affect Adial Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Adial Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adial Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adial Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.